372 related articles for article (PubMed ID: 23530148)
1. CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
Dessarthe B; Thedrez A; Latouche JB; Cabillic F; Drouet A; Daniel P; de La Pintière CT; Catros V; Toutirais O
J Immunol; 2013 May; 190(9):4868-76. PubMed ID: 23530148
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM.
Boles KS; Barchet W; Diacovo T; Cella M; Colonna M
Blood; 2005 Aug; 106(3):779-86. PubMed ID: 15811952
[TBL] [Abstract][Full Text] [Related]
3. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells.
Arase N; Takeuchi A; Unno M; Hirano S; Yokosuka T; Arase H; Saito T
Int Immunol; 2005 Sep; 17(9):1227-37. PubMed ID: 16091383
[TBL] [Abstract][Full Text] [Related]
4. [Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].
Catros V; Dessarthe B; Thedrez A; Toutirais O
Med Sci (Paris); 2014 May; 30(5):537-43. PubMed ID: 24939541
[TBL] [Abstract][Full Text] [Related]
5. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
[TBL] [Abstract][Full Text] [Related]
6. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
7. An abnormal phenotype of lung Vγ9Vδ2 T cells impairs their responsiveness in tuberculosis patients.
El Daker S; Sacchi A; Montesano C; Altieri AM; Galluccio G; Colizzi V; Martini F; Martino A
Cell Immunol; 2013 Apr; 282(2):106-12. PubMed ID: 23770719
[TBL] [Abstract][Full Text] [Related]
8. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Mattarollo SR; Kenna T; Nieda M; Nicol AJ
Cancer Immunol Immunother; 2007 Aug; 56(8):1285-97. PubMed ID: 17265022
[TBL] [Abstract][Full Text] [Related]
10. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
Todaro M; D'Asaro M; Caccamo N; Iovino F; Francipane MG; Meraviglia S; Orlando V; La Mendola C; Gulotta G; Salerno A; Dieli F; Stassi G
J Immunol; 2009 Jun; 182(11):7287-96. PubMed ID: 19454726
[TBL] [Abstract][Full Text] [Related]
11. Competition of cell adhesion and immune recognition: insights into the interaction between CRTAM and nectin-like 2.
Zhang S; Lu G; Qi J; Li Y; Zhang Z; Zhang B; Fan Z; Yan J; Gao GF
Structure; 2013 Aug; 21(8):1430-9. PubMed ID: 23871486
[TBL] [Abstract][Full Text] [Related]
12. Human Vgamma9Vdelta2 T cells: from signals to functions.
Nedellec S; Bonneville M; Scotet E
Semin Immunol; 2010 Aug; 22(4):199-206. PubMed ID: 20447835
[TBL] [Abstract][Full Text] [Related]
13. Rapid and transient activation of γδ T cells to IFN-γ production, NK cell-like killing, and antigen processing during acute virus infection.
Toka FN; Kenney MA; Golde WT
J Immunol; 2011 Apr; 186(8):4853-61. PubMed ID: 21383249
[TBL] [Abstract][Full Text] [Related]
14. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
Liu Z; Guo B; Lopez RD
J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
[TBL] [Abstract][Full Text] [Related]
15. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
[TBL] [Abstract][Full Text] [Related]
16. In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.
Benzaïd I; Mönkkönen H; Bonnelye E; Mönkkönen J; Clézardin P
Clin Cancer Res; 2012 Nov; 18(22):6249-59. PubMed ID: 23032740
[TBL] [Abstract][Full Text] [Related]
17. Chicken CRTAM binds nectin-like 2 ligand and is upregulated on CD8+ αβ and γδ T lymphocytes with different kinetics.
Zechmann M; Reese S; Göbel TW
PLoS One; 2013; 8(12):e81942. PubMed ID: 24339981
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
[TBL] [Abstract][Full Text] [Related]
19. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.
Fuchs A; Colonna M
Semin Cancer Biol; 2006 Oct; 16(5):359-66. PubMed ID: 16904340
[TBL] [Abstract][Full Text] [Related]
20. Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes.
Patiño-Lopez G; Hevezi P; Lee J; Willhite D; Verge GM; Lechner SM; Ortiz-Navarrete V; Zlotnik A
J Neuroimmunol; 2006 Feb; 171(1-2):145-55. PubMed ID: 16300832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
